Page 42 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

CHAPTER 2
118.Demoruelle MK, Weisman MH, Simonian PL, et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012; 64(6):1756–61.
119.Oken RJ, Schulzer M. At issue: schizophrenia and rheumatoid arthritis: the negative asso- ciation revisited. Schizophr Bull 1999;25(4):625–38.
120.Crowson CS, Matteson EL, Davis JM III, et al. Contribution of obesity to the rise in inci- dence of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013;65(1): 71–7.
121.de Hair MJ, Landewe RB, van de Sande MG, et al. Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann Rheum Dis 2013;72(10):1654–8.
122.Symmons DP, Bankhead CR, Harrison BJ, et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997;40(11):1955–61.
123.Wesley A, Bengtsson C, Elkan AC, et al. Association between body mass index and an- ti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis: results from a population-based casecontrol study. Arthritis Care Res (Hoboken) 2013;65(1):107–12.
124.Kang JH, Lin HC. Obstructive sleep apnea and the risk of autoimmune diseases: a longi- tudinal population-based study. Sleep Med 2012;13(6):583–8.
125.Maki-Petaja KM, Booth AD, Hall FC, et al. Ezetimibe and simvastatin reduce inflamma- tion, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 2007;50(9):852–8.
126.Steiner G, Urowitz MB. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 2009;38(5):372–81.
127.van de Stadt LA, van Sijl AM, van SD, et al. Dyslipidaemia in patients with seropositive arthralgia predicts the development of arthritis. Ann Rheum Dis 2012; 71(11):1915–6.
128.van Halm VP, Nielen MM, Nurmohamed MT, et al. Lipids and inflammation: serial mea- surements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 2007;66(2):184–8.
129.Myasoedova E, Crowson CS, Kremers HM, et al. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 2010;69(7):1310–4.
130.Dobson R, Giovannoni G. Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis. J Neurol 2013; 260(5):1272–85.
131.Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anticyclic citrullinat- ed protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006;65(7):845–51.
132.Berglin E, Padyukov L, Sundin U, et al. A combination of autoantibodies to cyclic citrul- linated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 2004;6(4):R303–8.
133.Brink M, Hansson M, Mathsson L, et al. Multiplex analyses of antibodies against citrul- linated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum 2013;65(4):899–910.
134.Dorner T, Hansen A. Autoantibodies in normals–the value of predicting rheumatoid ar- thritis. Arthritis Res Ther 2004;6(6):282–4.
40